Atomos Completes Flanders Buy for $2.35M Cash Plus Shares to Earn $1M EBITDA
Atomos has completed its acquisition of Flanders Scientific, Inc. (FSI) for approximately $2.35 million in cash plus 5,602,592 AMS shares. The transaction adds a global reference monitor brand to Atomos’ professional video ecosystem and is expected to contribute $1 million in annual EBITDA post-synergies.
Atomos completes Flanders Scientific acquisition, expanding professional monitoring ecosystem
Atomos has finalised the acquisition of 100% of the issued capital of Dan Desmet & Associates, Inc., trading as Flanders Scientific, Inc. The deal brings FSI’s highly calibrated professional reference monitors into the Atomos product portfolio, extending the company’s monitoring capabilities from on-camera capture through to final delivery in post-production.
FSI is recognised globally for expertise in colour science and reference display technology. The acquisition addresses critical customer challenges further along the video production workflow, complementing Atomos’ existing on-set monitoring solutions with tools designed for colourists, editors, and post-production professionals.
The transaction is structured as approximately $2.35 million in upfront cash consideration plus 5,602,592 AMS shares issued to the vendors. Post-integration synergies and before revenue growth, FSI is expected to generate annual EBITDA of $1 million, positioning the acquisition as earnings-accretive from the outset.
Completion was funded by Atomos’ new $10 million Business Finance Facility with Commonwealth Bank of Australia, announced on 10 April 2026.
When big ASX news breaks, our subscribers know first
What is a professional reference monitor and why does it matter?
Professional reference monitors are specialised displays used by colourists, editors, and cinematographers to ensure precise colour accuracy throughout post-production. Unlike standard screens, reference monitors are calibrated to industry standards, allowing professionals to see exactly how footage will appear to end viewers.
Colour science expertise is critical in this segment because any deviation from the creator’s intent during grading or editing can result in inconsistent viewing experiences across devices. FSI’s reputation is built on delivering highly calibrated monitors that professionals trust to maintain colour fidelity from production through to final delivery.
For Atomos, FSI’s niche addresses a complementary phase of the workflow. While Atomos already serves cinematographers and camera operators with on-camera monitoring tools, FSI targets the post-production suite where final colour grading and quality control occur.
CBA facility funds acquisition and accelerates growth initiatives
Atomos has executed security and financing documentation with Commonwealth Bank of Australia for a new $10 million Business Finance Facility. The facility funded the FSI completion payments, with remaining proceeds allocated to accelerate product development, increase inventory holdings, and provide general working capital for both Atomos and Flanders Scientific.
Key transaction metrics:
- Total facility size: $10 million
- Upfront FSI cash consideration: ~$2.35 million
- FSI shares issued: 5,602,592 AMS shares
- Expected annual EBITDA from FSI: $1 million (post synergies)
The CBA facility provides Atomos with execution capacity to support the integration whilst maintaining operational flexibility across both businesses.
Monreii facility amendment reduces borrowing costs
Concurrent with the CBA facility, Atomos executed an Amendment Deed under its existing Monreii facility, reducing funding costs from 20% per annum to 13%. The rate reduction delivers an annual saving of approximately $0.7 million.
Lower financing costs improve Atomos’ cost of capital and support cash flow during the FSI integration phase. The amendment reduces the company’s interest burden whilst it realises synergies across the combined business.
For investors, the restructured debt profile demonstrates improved access to institutional financing and positions the company to manage working capital more efficiently as it integrates FSI’s operations.
The next major ASX story will hit our subscribers first
CEO outlines integration priorities and customer response
Peter Barber, Managing Director & CEO
“We are excited to welcome the FSI business and team to Atomos and look forward to working closely together to furthering our commitment to monitoring at every level, from on-camera through to final delivery, while also accelerating our ability to support the highest tier of professional production and post-production workflows.”
Barber noted that initial customer reaction to the acquisition has been “very positive.” The company is now focused on an efficient integration process to realise synergies across the business.
Barber also acknowledged CBA’s support as Atomos executes its growth strategy, highlighting the institutional backing behind the transaction and the company’s broader expansion plans in professional video tools.
Investment thesis: expanding the professional monitoring ecosystem
The FSI acquisition broadens Atomos’ addressable market by capturing spend further along the production workflow. Atomos already serves on-camera monitoring through its recorder-monitor products; FSI adds post-production reference monitoring, where colour-critical work occurs before final output.
The strategic coherence is clear: Atomos can now offer monitoring solutions across the entire production chain, from onset capture through to final delivery. This positions the company to capture a larger share of professional production budgets as customers invest in end-to-end workflow solutions.
The immediate EBITDA contribution of $1 million de-risks the transaction by delivering earnings accretion before revenue growth initiatives take effect. Combined with the $0.7 million annual saving from the Monreii rate reduction, the acquisition improves both earnings and capital structure.
| Metric | Detail |
|---|---|
| Acquisition target | Flanders Scientific, Inc. (FSI) |
| Consideration | ~$2.35m cash + 5.6m AMS shares |
| Expected annual EBITDA | $1m (post synergies) |
| Financing cost saving | ~$0.7m p.a. (Monreii rate cut) |
For investors, the transaction represents a defensible expansion into a complementary professional segment backed by institutional financing and immediate earnings contribution.
Want the Next Consumer Breakthrough in Your Inbox?
Join 20,000+ investors getting FREE breaking ASX news delivered within minutes of release, complete with in-depth analysis. Click the “Free Alerts” button at StockWire X to receive alerts the moment market-moving announcements hit the market.